1. Academic Validation
  2. Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice

Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice

  • J Neuroimmunol. 2001 Mar 1;114(1-2):69-79. doi: 10.1016/s0165-5728(00)00434-3.
C Du 1 J J Bright S Sriram
Affiliations

Affiliation

  • 1 Department of Neurology, Multiple Sclerosis Research Center, Vanderbilt University Medical Center, 1222 VSRH, 2201 Capers Avenue, Nashville, TN 37212, USA.
Abstract

Activation of antigen presenting cells through the interaction of CD40 with its ligand is a critical co-stimulatory signal for IL-12 production and Th1 differentiation. Tyrphostins are organic molecules that inhibit the phosphorylation of Protein Tyrosine Kinases. We show that tyrphostin A1 inhibits CD40L-stimulated IL-12 production in macrophage cultures and antigen-induced generation of Th1 cells. Our data also show that tyrphostin A1 blocks CD40L-induced translocation of NF-kappaB to the nucleus, and reduces the activation of IL-12 p40 gene. In vivo therapy with A1 leads to decrease in generation of myelin basic protein (MBP) specific encephalitogenic T cells. In addition, treatment of SJL/J mice with A1 results in attenuation of experimental allergic encephalomyelitis (EAE).

Figures
Products